News

Through Save Legs. Change Lives.™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease

An analysis showed benefit of XARELTO® plus aspirin in reducing thrombotic hospitalizations for PAD patients with and without chronic kidney disease (CKD)

The SCAI released an official position statement aimed at providing recommendations to minimize the potential risks involved with medical proctoring.

A study led by Sumeet Chugh, MD, has the potential to enhance prevention of sudden cardiac arrest.

Ambient Experience with FlexVision display aims to help increases patient comfort, potentially improving interventional procedure workflows, outcomes, and productivity.

Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets

Data from RADIANCE-II will build on evidence from RADIANCE-HTN SOLO and TRIO studies to support pre-market application to the FDA.

The studies will assess the performance of its HLT Meridian® TAVR® Valve System to treat aortic stenosis and aortic regurgitation for high-risk patients suffering from aortic disease.

Stereotaxis robotic technology now in use in 25 countries St. Louis, March 25, 2021 — Stereotaxis, offering innovative robotic technologies for the treatment of cardiac arrhythmias, announced that Poland’s National Institute of Cardiology,...

Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary artery disease (CAD) according to an analysis recently published in The New England Journal of Medicine (NEJM).